基因治疗时间表

Same author

Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.

Diabetes, obesity & metabolism·2013

Same author

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.

Diabetes, obesity & metabolism·2012

Same author

MR safety: fast T₁ thermometry of the RF-induced heating of medical devices.

Magnetic resonance in medicine·2012

Same author

Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL.

Neurobiology of aging·2010

Same author

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.

Diabetes, obesity & metabolism·2009

Same author

Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer.

The British journal of surgery·2008

Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026

Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026

Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026

Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026

Same journal

Retraction.

Science (New York, N.Y.)·2026

Same journal

Making time.

Science (New York, N.Y.)·2026

相关实验视频

基因治疗时间表

相关概念视频

Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.

MR safety: fast T₁ thermometry of the RF-induced heating of medical devices.

Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL.

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.

Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer.

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Local signals, systemic decline.

The mechanics of liver regeneration.

Computing in a memory with physics.

Retraction.

Making time.

相关实验视频

基因治疗时间表

相关概念视频

相关文章

Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study.

MR safety: fast T₁ thermometry of the RF-induced heating of medical devices.

Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL.

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.

Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer.

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Local signals, systemic decline.

The mechanics of liver regeneration.

Computing in a memory with physics.

Retraction.

Making time.